Antigens, Tumor-Associated, Carbohydrate
"Antigens, Tumor-Associated, Carbohydrate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies.
Descriptor ID |
D015295
|
MeSH Number(s) |
D23.050.285.050 D23.050.550.325 D23.101.140.075
|
Concept/Terms |
Antigens, Tumor-Associated, Carbohydrate- Antigens, Tumor-Associated, Carbohydrate
- Carbohydrate Antigens, Tumor-Associated
- Antigens, Tumor-Associated Carbohydrate
- Carbohydrate Antigens, Tumor Associated
- Tumor-Associated Carbohydrate Antigens
- Tumor Associated Carbohydrate Antigens
- CA Antigen
- Antigen, CA
- Epitectin
- CA(Oxford) Antigen
- Cancer-Associated Carbohydrate Antigens
- Antigens, Cancer-Associated Carbohydrate
- Cancer Associated Carbohydrate Antigens
- Carbohydrate Antigens, Cancer-Associated
- Antigen, Carcinoma-Associated
- Antigen, Carcinoma Associated
- Carcinoma-Associated Antigen
- Carcinoma Associated Antigen
- Antigens, Carbohydrate, Tumor-Associated
- CA Antigens
- Antigens, CA
|
Below are MeSH descriptors whose meaning is more general than "Antigens, Tumor-Associated, Carbohydrate".
Below are MeSH descriptors whose meaning is more specific than "Antigens, Tumor-Associated, Carbohydrate".
This graph shows the total number of publications written about "Antigens, Tumor-Associated, Carbohydrate" by people in this website by year, and whether "Antigens, Tumor-Associated, Carbohydrate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, Tumor-Associated, Carbohydrate" by people in Profiles.
-
Guo X, Lv X, Fang C, Lv X, Wang F, Wang D, Zhao J, Ma Y, Xue Y, Bai Q, Yao X, Chen Y. Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling. Int J Cancer. 2016 10 15; 139(8):1821-9.
-
Nguyen LT, Elford AR, Murakami K, Garza KM, Schoenberger SP, Odermatt B, Speiser DE, Ohashi PS. Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance. J Exp Med. 2002 Feb 18; 195(4):423-35.